Phosphorus-containing macrocycles
This invention concerns a new family of phosphorus-containing macrocycles containing various phosphonate- and phosphonate-containing moieties.
1. A compound of the Formula I:
wherein:
A is independently —O—, —S— or —NR 2 —;
Q is V or VN(R)V; wherein V is independently an aliphatic, a heteroaliphatic, an aryl or a 5-14 membered heteroaryl moiety, having 1-4 heteroatoms selected from nitrogen, oxygen and sulfur;
J is:
each occurrence of X is independently H, —NR 2 R 5 , —OR 2 or halo;
one of R 7a and R 7b is H and the other is H, halo, —R A , —OR A , —SR A , —OC(O)R A , —OC(O)NR A R B , —NR A R B , —NR B C(O)R A , —NR B C(O)OR A , —NR B SO 2 R A , —OC(O)OR A , —NR B C(O)NR A R B or
—NR B SO 2 NR A R B ′; or R 7a and R 7b , taken together, are H in the tetraene moiety:
R A is R 2 , R B is OH or R 2 ;
R, R 2 and R 5 are independently selected from H, an aliphatic, a heteroaliphatic, an aryl and a 5-14 membered heteroaryl moiety having 1-4 heteroatoms selected from nitrogen, oxygen and sulfur;
R 28 is hydrogen, —COVH or COAQJ;
and n is 1 or 2;
wherein each aliphatic moiety contains 1-8 contiguous aliphatic carbon atoms, each heteroaliphatic moiety is an aliphatic moiety which contains an O, S, N, P or Si atom in place of one or more carbon atoms; and each of the foregoing aliphatic and heteroaliphatic moieties is independently branched or unbranched, or cyclic or acyclic, and unsubstituted or substituted with one or more groups selected from halogen, —YR 2 , —Y—C(═O)R 2 , —NR 2 C(═O)R 5 , —NR 2 C(═O)NR 5 , —NR 2 C(═O)OR 5 , —NR 2 C(═NH)NR 5 , —Y—C(═O)OR 2 , —Y—C(═O)NR 2 R 5 , —Y—C(═NR 2 )NR 2 R 5 , —COCOR 2 , —C(═O)(CH 2 ) r C(═O)R 2 , J, —CN, —S(═O)R 2 , —SO 2 R 2 , —SO 2 NR 2 R 5 , —NO 2 , —NR 5 SO 2 R 2 , —OSO 2 R 2 , —NR 5 SO 2 NR 2 R 5 , ═O, ═S, ═NR 2 , ═NNR 2 R 5 , ═NNHC(O)R 2 , ═NNHCO 2 R 2 , and ═NNHSO 2 R 2 , wherein Y is selected from a bond, —O—, NR 5 , and —S—, r is an integer of 1 to 4;
and each aryl or heteroaryl moiety is independently unsubstituted or substituted with one or more groups selected from halogen, —YR 2 , —Y—C(═O)R 2 , —NR 2 C(═O)R 5 , —NR 2 C(═O)NR 5 , —NR 2 C(═O)OR 5 , and —NR 2 C(═NR 2 )NR 5 , —Y—C(═O)OR 2 , —Y—C(═O)NR 2 R 5 , —Y—C(═NR 2 )NR 2 R 5 , —COCOR 2 , —C(═O)(CH 2 ) r C(═O)R 2 , J, —CN, —S(═O)R 2 , —SO 2 R 2 , —SO 2 NR 2 R 5 , —OSO 2 R 2 , —NO 2 , —NR 5 SO 2 R 2 and —NR 5 SO 2 NR 2 R; wherein Y is selected from a bond, —O—, NR 5 and —S—, r is an integer of 1 to 4.
2. A compound of the Formula II:
wherein:
A is independently —O—, —S— or —NR 2 —;
V is selected from the groups consisting of an aliphatic, a heteroaliphatic, an aryl and a 5-14 membered heteroaryl moiety, having 1-4 heteroatoms selected from nitrogen, oxygen and sulfur;
J is:
each occurrence of X is independently H, —NR 2 R 5 , —OR 2 or halo;
one of R 7a and R 7b is H and the other is H, halo, —R A , —OR A , —SR A , —OC(O)R A , —OC(O)NR A R B , —NR A R B , —NR B C(O)R A , —NR B C(O)OR A , —NR B SO 2 R A , —OC(O)OR A , —NR B C(O)NR A R B , or
—NR B SO 2 NR A R B ′; or R 7a and R 7b , taken together, are H in the tetraene moiety:
R A is R 2 , R B is OH or R 2 , (in some cases one or both of R A and R B is H);
R, R 2 and R 5 are independently selected from H, an aliphatic, a heteroaliphatic, an aryl and a 5-14 membered heteroaryl moiety having 1-4 heteroatoms selected from nitrogen, oxygen and sulfur;
R 28 is hydrogen, —COVH or COAQJ;
and n is 1 or 2;
wherein each aliphatic moiety contains 1-8 contiguous aliphatic carbon atoms, each heteroaliphatic moiety is an aliphatic moiety which contains an O, S, N, P or Si atom in place of one or more carbon atoms; and each of the foregoing aliphatic and heteroaliphatic moieties is independently branched or unbranched, or cyclic or acyclic, and unsubstituted or substituted with one or more groups selected from halogen, —YR 2 , —Y—C(═O)R 2 , —NR 2 C(═O)R 5 , —NR 2 C(═O)NR 5 , —NR 2 C(═O)OR 5 , —NR 2 C(═NH)NR 5 , —Y—C(═O)OR 2 , —Y—C(═O)NR 2 R 5 , —Y—C(═NR 2 )NR 2 R 5 , —COCOR 2 , —C(═O)(CH 2 ) r C(═O)R 2 , J, —CN, —S(═O)R 2 , —SO 2 R 2 , —SO 2 NR 2 R 5 , —NO 2 , —NR 5 SO 2 R 5 , —OSO 2 R 2 , —NR 5 SO 2 NR 2 R 5 , ═S, ═NR 2 , ═NNR 2 R 5 , ═NNHC(O)R 2 , ═NNHCO 2 R 2 , and ═NNHSO 2 R 2 , wherein Y is selected from a bond, —O—, NR 5 and —S—, r is an integer of 1 to 4;
and each aryl or heteroaryl moiety is independently unsubstituted or substituted with one or more groups selected from halogen, —YR 2 , —Y—C(═O)R 2 , —NR 2 C(═O)R 5 , —NR 2 C(═O)NR 5 , —NR 2 C(═O)OR 5 , and —NR 2 C(═NR 2 )NR 5 , —Y—C(═O)OR 2 , —Y—C(═O)NR 2 R 5 , —Y—C(═NR 2 )NR 2 R 5 , —COCOR 2 , —C(═O)(CH 2 ) r C(═O)R 2 , J, —CN, —S(═O)R 2 , —SO 2 R 2 , —SO 2 NR 2 R 5 , —OSO 2 R 2 , —NO 2 , —NR 5 SO 2 R 2 and —NR 5 SO 2 NR 2 R; wherein Y is selected from a bond, —O—, NR 5 and —S—, r is an integer of 1 to 4.
3. The compound of claim 2 having the formula II(a):
in which m is an integer from 2 through 8.
4. The compound of claim 3 having the formula II(b):
5. The compound of claim 3 having the formula II(d):
6. The compound of claim 2 having the formula II(e):
wherein Z is CH or N.
7. The compound of any of claims 3 , 4 and 6 wherein one or both of R and R 2 groups are H.
8. The compound of any of claims 3 , 4 and 6 wherein one or both R and R 2 groups are C1-C8 alkyl groups.
9. The compound of any of claims 3 , 4 and 6 wherein one or both R and R 2 groups are CH 3 .
10. The compound of any of claims 1 - 6 wherein n is 2; R 28 is H; R 7a is OMe and R 7b is H.
11. The compound of claim 4 having the formula II(f):
wherein JV— is selected from the following:
and wherein p is 0, 1, 2, 3, 4 or 5and Z is N or CH.
12. The compound of claim 1 of the formula III(a):
13. The compound of claim 12 wherein A is O or NR 2 .
14. The compound of claim 12 wherein V is a 1-8-carbon alkyl moiety.
15. The compound of claim 12 wherein V is an aryl or a 5-14 membered heteroaryl moiety having 1-4 heteroatoms selected from nitrogen, oxygen, or sulfur.
16. The compound of claim 12 of the formula III(b):
wherein JVNR 2 —C(O)— is selected from the following:
17. The compound of claim 12 of the formula III(c):
wherein JVOC(O)— is selected from:
18. A composition comprising a compound of claim 1 , together with a pharmaceutically acceptable vehicle and optionally containing one or more pharmaceutically acceptable excipients.